Skip to main content

Table 1

From: Meeting program

Treatment

n(%)

Total patients treated w/epinephrine

102 (79.1)

EpiPen (self-administered)

24 (18.6)

Epinephrine via ED personnel

86 (66.7)

IV access secured

76 (58.9)

IV fluid bolus

35 (27.1)

H1 antagonists

122 (94.6)

H2 antagonists

32 (24.8)

Corticosteroids

64 (49.6)

β2-Agonists

38 (29.5)

Admitted to hospital after initial mgt

8 (6.2)

Discharge Dx = anaphylaxis

53 (41.1)

EpiPen prescribed on discharge

76 (58.9)

Discharge therapy/adviceDischarge prescription including corticosteroids

37 (28.7)8 (6.2)